IntegraGen SA (ALINT) Stock Statistics & Valuation Metrics

IntegraGen SA has a market cap or net worth of €1.57M. The enterprise value is €297.91K.

IntegraGen SA has 6,727,332 shares outstanding. The number of shares has decreased by -2.65% in one year.

IntegraGen SA’s return on equity (ROE) is -0.09 and return on invested capital (ROIC) is -3.68%.

The current PE Ratio of IntegraGen SA is -34.49. IntegraGen SA’s PEG ratio is <0.01.

In the last 12 months, IntegraGen SA had revenue of 12.54M and earned -171.40K in profits. Earnings per share was -0.03.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

IntegraGen SA pays an annual dividend of ―, resulting in a dividend yield of ―

IntegraGen SA upcoming earnings date is Oct 16, 2025, TBA (Confirmed).

IntegraGen SA as a current ratio of 1.48, with Debt / Equity ratio of 36.64%

In the past 12 months, IntegraGen SA has paid -87.68K in taxes.

IntegraGen SA EV to EBITDA ratio is -99.09, with an EV/FCF ratio of 0.00.

IntegraGen SA has €2.88M in cash and marketable securities with €1.12M in debt, giving a net cash position of -€1.75M billion.

Gross margin is 6.08%, with operating margin of -1.47%, and net profit margin of -1.37%.

The average price target for IntegraGen SA is ―, which is 11.43% higher than the current price. The consensus rating is ―